| Name | Title | Contact Details |
|---|
Berg Pharma focuses research on understanding how alterations in metabolism relate to disease onset. The company has a deep pipeline of early-stage technologies in CNS diseases and metabolic diseases that complement its late-stage clinical trial activity in cancer and prevention of chemotoxicity. Armed with use of the Berg Interrogative Biology™ discovery platform that translates biological output into therapeutic candidates, Berg Pharma is well positioned for rapid commercialization of its intellectual capital.
International Center for Toxicology and Medicine is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Phagetech is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neotropix is a Malvern, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Taylst is a Kirkland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.